C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis

類似資料

• Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
  著者:: Ishida, Natsuki, 等
  出版事項: (2021)
• Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis
  著者:: Tamura, Satoshi, 等
  出版事項: (2021)
• Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
  著者:: Ishida, Natsuki, 等
  出版事項: (2020)
• Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
  著者:: Ishida, Natsuki, 等
  出版事項: (2020)
• Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease
  著者:: Ishida, Natsuki, 等
  出版事項: (2021)